AbbVie’s (ABBV) Q4 Earnings Surpass Estimates, Sales Miss

Posted byZacks Equity Research Leave a comment on AbbVie’s (ABBV) Q4 Earnings Surpass Estimates, Sales Miss

AbbVie (ABBV) beats fourth-quarter 2021 earnings estimates while missing the same for sales. Strong demand for immunology drugs, aesthetics and cosmetics drives sales. Shares up.

Leave a comment

Your email address will not be published. Required fields are marked *